Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Biotech
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
While the biotech has yet to unveil a more detailed data set, the injection, dubbed MET-097, was tied to “significant and durable” weight loss.
Gabrielle Masson
Sep 24, 2024 7:00am
Sanofi makes $27M equity investment in Ventyx
Sep 23, 2024 11:24am
Novo hails ‘remarkable’ weight loss result for experimental pill
Sep 11, 2024 11:02am
Zealand Pharma’s GLP-1/GLP-2 agonist tied to 8.3% weight loss
Sep 10, 2024 10:45am
Lilly, Haya ink $1B biobuck obesity pact to search dark genome
Sep 4, 2024 8:00am
MBX files for IPO to take challenger to Ascendis into phase 3
Aug 26, 2024 9:40am